Starling Oncology, Inc. Unrealized Gain (Loss) on Derivatives
Starling Oncology, Inc. (DFPH) reported Unrealized Gain (Loss) on Derivatives of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-28.
Discontinued › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnDerivatives · last filed 2024-03-28
- Starling Oncology, Inc. unrealized gain (loss) on derivatives for the quarter ending 2023-12-31 was $0.00, a 100.00% decline year-over-year.
- Starling Oncology, Inc. unrealized gain (loss) on derivatives for the quarter ending 2022-12-31 was $34.63M.
- Starling Oncology, Inc. unrealized gain (loss) on derivatives for the quarter ending 2022-09-30 was $13.97M.
- Starling Oncology, Inc. unrealized gain (loss) on derivatives for the quarter ending 2021-12-31 was $0.00.
- Starling Oncology, Inc. unrealized gain (loss) on derivatives for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- Starling Oncology, Inc. unrealized gain (loss) on derivatives for fiscal 2022 was $20.66M.
- Starling Oncology, Inc. unrealized gain (loss) on derivatives for fiscal 2021 was $0.00.
| Period end | Unrealized Gain (Loss) on Derivatives 3 month | Unrealized Gain (Loss) on Derivatives 6 month | Unrealized Gain (Loss) on Derivatives 9 month | Unrealized Gain (Loss) on Derivatives 9 month as first filed | Unrealized Gain (Loss) on Derivatives 12 month |
|---|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $0.00 10-K · filed 2024-03-28 | |||
| 2023-09-30 | $0.00 10-Q · filed 2023-11-08 | ||||
| 2022-12-31 | $34.63M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $48.60M derived: sum of 2 quarters · filed 2024-03-28 | $20.66M 10-K · filed 2024-03-28 | ||
| 2022-09-30 | $13.97M 10-Q · filed 2022-11-09 | -$13.97M 10-Q · filed 2023-11-08 | $13.97M 10-Q · filed 2022-11-09 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $0.00 derived: sum of 2 quarters · filed 2023-03-16 | $0.00 10-K · filed 2023-03-16 | ||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-09 | $0.00 10-Q · filed 2022-11-09 |